The history of photodetection and photodynamic therapy

Photochemistry and Photobiology

Volumn 74, Issue 5, 2001, Pages 656-669

  Ackroyd, Roger ^a,b   Kelty, Clive ^a   Brown, Nicola ^a   Reed, Malcolm ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID; ASPARTYLCHLORIN E6; BENZOPORPHYRIN DERIVATIVE; HEMATOPORPHYRIN; HEMATOPORPHYRIN DERIVATIVE; LUTETIUM TEXAPHYRIN; PHOTOFRIN; PHOTOFRIN II; PHOTOSENSITIZING AGENT; PHTHALOCYANINE DERIVATIVE; PORPHYRIN; PURLYTIN; TETRAKIS(3 HYDROXYPHENYL)CHLORIN; TEXAPHYRIN DERIVATIVE; TIN ETHYLETIOPURPURIN; UNCLASSIFIED DRUG;

ARTICLE; ATHEROSCLEROTIC PLAQUE; BLADDER CARCINOMA; BRAIN CANCER; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER THERAPY; CLINICAL TRIAL; DIAGNOSTIC PROCEDURE; DRUG ERUPTION; DRUG MECHANISM; ESOPHAGUS CARCINOMA; HEAD AND NECK CANCER; HISTORY OF MEDICINE; HUMAN; LIGHT; LIGHT DETECTION; LUNG CARCINOMA; PARESTHESIA; PHOTOCHEMOTHERAPY; PHOTODYNAMIC THERAPY; PHOTOSENSITIVITY; PHOTOTHERAPY; PHOTOTOXICITY; RETINA MACULA AGE RELATED DEGENERATION; SIDE EFFECT; SKIN CARCINOMA; SKIN TOXICITY;

AMINOLEVULINIC ACID; HEMATOPORPHYRINS; HUMANS; NEOPLASMS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PHOTOTHERAPY; PORPHYRINS;

EID: 0035526535     PISSN: 00318655     EISSN: None     Source Type: Journal    
DOI: 10.1562/0031-8655(2001)074<0656:THOPAP>2.0.CO;2     Document Type: Article

References (155)

1. Weishaupt, K. R., C. J. Gomer and T. J. Dougherty (1976) Identification of singlet oxygen as cytotoxic agent in photo-inactivation of a murine tumor. Cancer Res. 36, 2326-2329.
2. Dougherty, T. J., G. B. Grinday, R. Fiel, K. R. Weishaupt and D. G. Boyle (1975) Photoradiation therapy II: cure of animal tumors with haematoporphyrin and light. J. Natl. Cancer Inst. 55, 115-121.
3. Pass, H. I. (1993) Photodynamic therapy in oncology: mechanisms and clinical use. J. Natl. Cancer Inst. 85, 443-456.
4. Daniell, M. D. and J. S. Hill (1991) A history of photodynamic therapy. Aust. N.Z. J. Surg. 61, 340-348.
5. Spikes, J. D. (1985) The historical development of ideas on applications of photosensitised reactions in health sciences. In Primary Photoprocesses in Biology and Medicine (Edited by R. V. Bergasson, G. Jori, E. J. Land and T. G. Truscott), pp. 209-227. Plenum Press, New York.
6. Epstein, J. M. (1990) Phototherapy and photochemotherapy. N. Engl. J. Med. 32, 1149-1151.
7. Cauvin, J. F. (1815) Des bienfaits de l'insolation. Ph.D. Thesis, University of Paris, France.
8. Finsen, N. R. (1901) Phototherapy. Edward Arnold, London.
9. Fitzpatrick, T. B. and M. A. Pathak (1959) Historical aspects of methoxsalen and other furocoumarins. J. Investig. Dermatol. 23, 229-231.
10. Raab, O. (1900) Uber die Wirkung fluoreszierender Stoffe auf Infusorien. Z. Biol. 39, 524-546.
11. Von Tappeiner, H. (1900) Uber die Wirkung fluoreszierender Stoffe auf Infusorien nach Versuchen von O. Raab. Muench. Med. Wochenschr. 47, 5.
12. Prime, J. (1900) Les accidentes toxiques par l'eosinate de sodium. Jouve and Boyer, Paris.
13. Von Tappeiner, H. and A. Jesionek (1903) Therapeutische Versuche mit fluoreszierenden Stoffen. Muench. Med. Wochenschr. 47, 2042-2044.
14. Von Tappeiner, H. and A. Jodlbauer (1904) Uber Wirkung der photodynamischen (fluorieszierenden) Stoffe auf Protozoan und Enzyme. Dtsch. Arch. Klin. Med. 80, 427-487.
15. Von Tappeiner, H. and A. Jodlbauer (1907) Die Sensibilisierende Wirkung fluorieszierender Substanzer. Gesammte Untersuchungen uber die photodynamische Erscheinung. F. C. W. Vogel, Leipzig.
16. Scherer, H. (1841) Chemisch-physiologische untersuchungen. Ann. Chem. Pharm. 40, 1.
17. Thudichum, J. L. (1867) Tenth Report of the Medical Officer of the Privy Council. H. M. Stationary Office, London.
18. Hoppe-Seyler, F. (1871) Med. Chem. Untersuchungen. Eberhard-Karls-Universitat, Berlin.
19. Hausmann, W. (1911) Die sensibilisierende Wirkung des Hematoporphyrins. Biochem. Z. 30, 276-316.
20. Meyer-Betz, F. (1913) Untersuchungen uber die Biologische (photodynamische) Wirkung des Hamatoporphyrins und anderer Derivative des Blut- und Galenfarbstoffs. Dtsch. Arch. Klin. Med. 112, 476-503.
21. Policard, A. (1924) Etudes sur les aspects offerts par des tumeurs experimentales examinees a la lumiere de Wood. C. R. Soc. Biol. 91, 1423-1428.
22. Auler, H. and G. Banzer (1942) Untersuchungen uber die Rolle der Porphyrine bei geschwulstkranken Menschen und Tieren. Z. Krebsforsch. 53, 65-68.
23. Figge, F. H. J. and G. S. Weiland (1948) The affinity of neoplastic embryonic and traumatized tissue for porphyrins and metalloporphyrins. Anat. Rec. 100, 659.
24. Figge, F. H. J., G. S. Weiland and L. O. J. Manganiello (1948) Cancer detection and therapy. Affinity of neoplastic, embryonic and traumatized regenerating tissues for porphyrins and metalloporphyrins. Proc. Soc. Exp. Biol. Med. 68, 640-641.
25. Manganiello, L. O. J. and F. H. J. Figge (1951) Cancer detection and therapy II. Methods of preparation and biological effects of metalloporphyrins. Bull. School Med., Univ. Maryland 36, 3-7.
26. Rassmussan-Taxdal, D. S., G. E. Ward and F. H. J. Figge (1955) Fluorescence of human lymphatic and cancer tissues following high doses of intravenous hematoporphyrin. Cancer 8, 78-81.
27. Peck, G. C., H. P. Mack and W. A. Holbrook (1955) Use of hematoporphyrin fluorescence in biliary and cancer surgery. Ann. Surg. 21, 181-188.
28. Schwartz, S. K., K. Absolon and H. Vermund (1955) Some relationships of porphyrins, x-rays and tumours. Univ. Minn. Med. Bull. 27, 7-8.
29. Lipson, R. L. and E. J. Baldes (1960) The photodynamic properties of a particular hematoporphyrin derivative. Arch. Dermatol. 82, 508-516.
30. Lipson, R. L., E. J. Baldes and A. M. Olsen (1961) The use of a derivative of hematoporphyrin in tumor detection. J. Natl. Cancer Inst. 26, 1-11.
31. Lipson, R. L., E. J. Baldes and A. M. Olsen (1961) Hematoporphyrin derivative: a new aid for endoscopic detection of malignant disease. J. Thorac. Cardiovasc. Surg. 42, 623-629.
32. Lipson, R. L., E. J. Baldes and M. J. Gray (1967) Hematoporphyrin derivative for detection and management of cancer. Cancer 20, 255-257.
33. Gray, M. J., R. L. Lipson, J. V. S. Maeck, L. Parker and D. Romeyn (1967) Use of hematoporphyrin derivative in detection and management of cervical cancer. Am. J. Obstet. Gynecol. 99, 766-771.
34. Gregorie, H. B. Jr., E. O. Horger, J. L. Ward, J. F. Green, T. Richards, H. C. Robertson Jr. and T. B. Stevenson (1968) Hematoporphyrin derivative fluorescence in malignant neoplasms. Ann. Surg. 167, 829.
35. Leonard, J. R. and W. L. Beck (1971) Hematoporphyrin fluorescence: an aid to diagnosis of malignant neoplasms. Laryngoscope 81, 365-372.
36. Kyriazis, G. A., H. Balin and R. L. Lipson (1973) Hematoporphyrin derivative fluorescence test colposcopy and colpophotography in the diagnosis of atypical metaplasia, dysplasia and carcinoma in situ of the cervix uteri. Am. J. Obstet. Gynecol. 117, 375-380.
37. Kinsey, J. H., D. A. Cortese and D. R. Sanderson (1978) Detection of hematoporphyrin fluorescence during fibreoptic bronchoscopy to localize early bronchogenic carcinoma. Mayo Clin. Proc. 53, 594-600.
38. Cortese, D. A., J. H. Kinsey, L. B. Woolner, W. S. Payne, D. R. Sanderson and R. S. Fontana (1979) Clinical application of a new endoscopic technique for detection of in situ bronchial carcinoma. Mayo Clin. Proc. 54, 635-642.
39. Profio, A. E. and D. R. Doiron (1979) Laser fluorescence bronchoscope for localization of occult lung tumours. Med. Phys. 6, 523-525.
40. Hayata, Y. and D. J. Dougherty (Eds.)(1983) Laser and Hematoporphyrin Derivative in Cancer. Igaku-Shoin, Tokyo.
41. Hayata, Y., H. Kato, C. Konaka, J. Ono, Y. Matsushima, K. Yoneyama and K. Nishimiya (1982) Fiberoptic bronchoscopic laser photoradiation for tumor localization in lung cancer. Chest 82, 10-14.
42. Benson, R. C. Jr., J. H. Kinsey, D. A. Cortese, G. M. Farrow and D. C. Utz (1983) Treatment of transitional cell carcinoma of the bladder with hematopophyrin derivative phototherapy. J. Urol. 130, 1090-1094.
43. Profio, A. E. and D. R. Doiron (1987) Dose measurement in photodynamic therapy of cancer. Lasers Surg. Med. 7, 71-75.
44. Diamond, I., S. G. Granelli, A. F. McDonagh, S. Nielsen, C. B. Wilson and R. Jaenicke (1972) Photodynamic therapy of malignant tumours. Lancet 2, 1175-1177.
45. Kelly, J. F., M. E. Snell and M. C. Berenbaum (1975) Photodynamic destruction of human bladder carcinoma. Br. J. Cancer 31, 237-244.
46. Kelly, J. F. and M. E. Snell (1976) Hematoporphyrin derivative: a possible aid in the diagnosis and treatment of carcinoma of the bladder. J. Urol. 115, 150-151.
47. Dougherty, T. J. (1978) Photoradiation therapy for the treatment of malignant tumours. Cancer Res. 36, 2628-2635.
48. Wile, A. G., A. Dahlman, R. Burns and M. W. Berns (1982) Laser photoradiation therapy of cancer following hematoporphyrin sensitization. Lasers Surg. Med. 2, 163-168.
49. Wile, A. G., J. Coffey, B. S. Nahabedian, R. Baghdassarian, G. R. Mason and M. W. Berns (1984) Laser photoradiation therapy of cancer: an update of the experience at the University of California, Irvine. Lasers Surg. Med. 4, 5-12.
50. Tomio, L., F. Calzavara, P. L. Zorat, L. Corti, C. Polico, E. Reddi, G. Jori and G. Mandoliti (1984) Photoradiation therapy for cutaneous and subcutaneous malignant tumors using hematoporphyrin. In Porphyrin Localization and Treatment of Tumors (Edited by D. R. Doiron and C. J. Gomer), pp. 829-840. A. R. Liss, New York.
51. Dougherty, T. J. (1987) Photosensitizers: therapy and detection of malignant tumors. Photochem. Photobiol. 45, 879-889.
52. Balchum, O. J., D. R. Doiron and G. C. Huth (1984) Photoradiation therapy for endobronchial lung cancers employing the photodynamic action of hematoporphyrin derivative. Lasers Surg. Med. 4, 13-30.
53. Lam, S., N. L. Muller, R. R. Miller, E. C. Kostashuk, I. J. Szasz, J. C. LeRiche and E. Lee-Chuy (1986) Predicting the response of obstructive endobronchial tumors to photodynamic therapy. Cancer 58, 2298-2306.
54. Lo Cicero, J. III, M. Metzdorff and C. Almgren (1990) Photodynamic therapy in the palliation of late stage obstructing non-small cell lung cancer. Chest 98, 97-100.
55. Hayata, Y., H. Kato, C. Konaka, J. Ono and N. Takizawa (1982) Hematoporphyrin derivative and laser photoradiation in the treatment of lung cancer. Chest 81, 269-277.
56. Cortese, D. A. and J. H. Kinsey (1984) Hematoporphyrin derivative phototherapy in the treatment of bronchogenic carcinoma. Chest 86, 8.
57. Ohi, T. and A. Tsuchiya (1983) Superficial bladder tumours. In Lasers and Hematoporphyrin Derivative in Cancer (Edited by Y. Hayata and T. J. Dougherty), pp. 79-84. Igaku-Shoin, Tokyo.
58. Schumaker, B., M. D. Lutz and G. Haas (1985) Diagnosis and treatment of carcinoma in-situ of the urinary bladder with hematoporphyrin derivative and laser phototherapy. Lasers Med. Surg. 5, 194.
59. Prout, G. R., C. W. Lin, R. Benson, U. O. Nseyo, J. J. Daly, P. P. Griffin, J. Kinsey, M. E. Tian, Y. H. Lao and Y. Z. Mian (1987) Photodynamic therapy with hematoporphyrin derivative in the treatment of superficial transitional cell carcinoma of the bladder. N. Engl. J. Med. 317, 1251-1255.
60. McCaughan, J. S., W. Hicks, L. Laufman, E. May and R. Roach (1984) Palliation of oesophageal malignancy with photoradiation therapy. Cancer 54, 2905-2910.
61. Hayata, Y., K. Harubumi, H. Okitsu, M. Kawaguchi and C. Konaka (1985) Photodynamic therapy with hematoporphyrin derivative in cancer of the upper gastro-intestinal tract. Semin. Surg. Oncol. 1, 1-11.
62. Sibille, A., R. Lambert, J. C. Souquet, G. Sabben and F. Descos (1995) Long-term survival after photodynamic therapy for esophageal cancer. Gastroenterology 108, 337-344.
63. Ward, B. G., I. J. Forbes, P. A. Cowled, M. M. McEvoy and L. W. Cox (1982) The treatment of vaginal recurrences of gynecological malignancy with phototherapy following hematoporphyrin derivative pre-treatment. Am. J. Obstet. Gynecol. 142, 356-357.
64. Gomer, C. J., D. R. Doiron, J. V. Jester, B. C. Szirth and A. L. Murphree (1983) Hematoporphyrin derivative photoradiation therapy for the treatment of intraocular tumors: examination of acute normal ocular toxicity. Cancer Res. 43, 721-727.
65. Tse, D. T., J. J. Dutton, T. A. Weingeist, V. M. Hermsen and R. C. Kersten (1984) Hematoporphyrin photoradiation therapy for intra-ocular and orbital malignant melanoma. Arch. Ophthamol. 102, 833-838.
66. Sandeman, D. R. (1986) Photodynamic therapy in the management of malignant gliomas: a review. Lasers Med. Sci. 1, 163-173.
67. Hill, J. S., A. H. Kaye, W. H. Sawyer, G. Morstyn, P. D. Megison and S. S. Stylli (1990) Selective uptake of hematoporphyrin derivative into human cerebral glioma. Neurosurgery 26, 248-254.
68. Schweitzer, V. G. (1990) Photodynamic therapy for treatment of head and neck cancer. Otolaryngol. Head Neck Surg. 102, 225-232.
69. Wenig, B. L., D. M. Kurtzman, L. I. Grossweiner, M. F. Mafee, D. M. Harris, R. V. Lobraico, R. A. Prycz and E. L. Appelbaum (1990) Photodynamic therapy in the treatment of squamous cell carcinoma of the head and neck. Arch. Otolaryngol. Head Neck Surg. 116, 1267-1270.
70. Barr, H., N. Krasner, P. B. Boulos, P. Chatlani and S. G. Bown (1990) Photodynamic therapy for colorectal cancer: a quantitative pilot study. Br. J. Surg. 77, 93-96.
71. Dougherty, T. J., C. J. Gomer, B. W. Henderson, G. Jori, D. Kessel, M. Korbelik, J. Moan and Q. Peng (1998) Photodynamic therapy. J. Natl. Cancer Inst. 90, 889-905.
72. Henderson, B. W. and T. J. Dougherty (1992) How does photodynamic therapy work? Photochem. Photobiol. 55, 145-157.
73. Henderson, B. W., T. J. Dougherty and P. B. Malone (1984) Studies on the mechanism of tumor destruction by photoradiation therapy. In Porphyrin Localization and Treatment of Tumors (Edited by D. R. Doiron and C. J. Gomer), pp. 301-314. A. R. Liss, New York.
74. Star, W. M., H. P. Marijnissen, A. E. van den Berg-Blok, J. A. Versteeg, K. A. Franken and H. S. Reinhold (1986) Destruction of rat mammary tumor and normal tissue microcirculation by hematoporphyrin derivative photoradiation observed in vivo in sandwich observation chambers. Cancer Res. 46, 2532-2540.
75. Reed, M. W., T. J. Wieman, D. A. Schuschke, M. T. Tseng and F. N. Miller (1989) A comparison of the effects of photodynamic therapy on normal and tumor blood vessels in the rat microcirculation. Radiat. Res. 119, 542-552.
76. Peng, Q., J. Moan and J. M. Nesland (1996) Correlation of subcellular and intratumoral photosensitizer localization with ultrastructural features after photodynamic therapy. Ultrastruct. Pathol. 20, 109-129.
77. Moan, J. and K. Berg (1991) The photodegradation of porphyrins in cells can be used to estimate the lifetime of singlet oxygen. Photochem. Photobiol. 53, 549-553.
78. Agarwal, M. L., M. E. Clay, E. J. Harvey, H. H. Evans, A. R. Antunez and N. L. Oleinick (1991) Photodynamic therapy induces rapid cell death by apoptosis in L5178Y mouse lymphoma cells. Cancer Res. 51, 5993-5996.
79. Kessel, D. and Y. Luo (1998) Mitochondrial photodamage and PDT-induced apoptosis. J. Photochem. Photobiol. B: Biol. 42, 89-95.
80. Moor, A. C. (2000) Signaling pathways in cell death and survival after photodynamic therapy. J. Photochem. Photobiol. B: Biol. 57, 1-13.
81. Fingar, V. H. (1996) Vascular effects of photodynamic therapy. J. Clin. Laser Med. Surg. 14, 323-328.
82. Korbelik, M. (1996) Induction of tumor immunity by photodynamic therapy. J. Clin. Laser Med. Surg. 14, 329-334.
83. Korbelik, M. and I. Cecic (1999) Contribution of myeloid and lymphoid host cells to the curative outcome of mouse sarcoma treatment by photodynamic therapy. Cancer Lett. 137, 91-98.
84. MacDonald, I. J. and T. J. Dougherty (2001) Basic principles of photodynamic therapy. J. Porphyrin Phthalocyanines 5, 105-129.
85. Dougherty, T. J. (1983) Hematoporphyrin as a photosensitizer of tumors. Photochem. Photobiol. 38, 377-379.
86. Dougherty, T. J., W. R. Potter and K. R. Weishaupt (1984) The structure of the active component of hematoporpyyrin derivative. In Porphyrin Localization and Treatment of Tumors (Edited by D. R. Doiron and C. J. Gomer), pp. 301-314. A. R. Liss, New York.
87. Kessel, D., P. Thompson, B. Musselman and C. K. Chang (1987) Chemistry of hematoporphyrin derived photosensitisers. Photochem. Photobiol. 46, 563-568.
88. Bown, S. G., C. J. Tralau, P. D. Coleridge-Smith, D. Akdemir and T. J. Wieman (1986) Photodynamic therapy with porphyrin and phthalocyanine sensitisation: quantitative studies in normal rat liver. Br. J. Cancer 54, 43-52.
89. Chan, W. S., R. Svensen, D. Philips and I. R. Hart (1986) Cell uptake, distribution and response to aluminium chloro-sulphonated phthalocyamine, a potential anti-tumour photosensitizer. Br. J. Cancer 53, 255-263.
90. Pope, A. J. and S. G. Bown (1991) The morphological and functional changes in rat bladder following photodynamic therapy with phthalocyanine photosensitization. J. Urol. 145, 1064-1070.
91. Berenbaum, M. C., S. L. Akande, R. Bonnett, H. Kaur, S. Ioannou, R. D. White and U. J. Winfield (1986) Meso-tetra (hydroxyphenyl) porphyrins, a new class of potent tumour photosensitizers with favourable selectivity. Br. J. Cancer 54, 717-727.
92. Chevretton, E. B., M. C. Berenbaum and R. Bonnett (1992) The effect of photodynamic therapy on normal skeletal muscle in an animal model. Lasers Med. Sci. 7, 103-110.
93. Berenbaum, M., R. Bonnett and E Cheorettan (1993) Selectivity of meso-tetra-(hydroxyphenyl) porphyrins and chlorines and photofrin in causing photodamage in tumor, skin, muscle and bladder. Lasers Med. Sci. 8, 235-243.
94. Drabkin, D. L. (1963) Introduction: some historical highlights in knowledge of porphyrins and porphyrias. Ann. N. Y. Acad. Sci. 104, 658.
95. Granick, S. (1965) Hepatic porphyria and drug-induced or chemical porphyria. Ann. N. Y. Acad. Sci. 123, 188.
96. Divaris, D. X. G., J. C. Kennedy and R. H. Pottier (1990) Phototoxic damage to sebaceous glands and hair follicles of mice after systemic administration of 5-aminolaevulinic acid correlates with localized protoporphyrin production. Am. J. Pathol. 136, 891-897.
97. Elder, G. H. (1994) Haem synthesis and the porphyrias. In Scientific Foundations of Biochemistry in practise (Edited by D. L. Williams and V. Marks), pp. 175-186. Heineman, London.
98. Kennedy, J. C. and R. H. Pottier (1992) Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. J. Photochem. Photobiol. B: Biol. 14, 275-292.
99. Pottier, R. H., Y. F. A. Chow, J. P. La Plante, T. G. Truscott, J. C. Kennedy and L. A. Beiner (1986) Non-invasive technique for obtaining fluorescence excitation and emission spectra in vivo. Photochem. Photobiol. 44, 679-687.
100. Loh, C. S., D. I. Vernon, A. J. MacRobert, J. Bedwell, S. G. Bown and S. B. Brown (1993) Endogenous porphyrin distribution induced by 5-aminolaevulinic acid in the tissue layers of the gastrointestinal tract. J. Photochem. Photobiol. B: Biol. 20, 47-54.
101. Wyld, L., J. L. Burn, M. W. Reed and N. J. Brown (1997) Factors affecting aminolaevulinic acid-induced generation of protoporphyrin IX. Br. J. Cancer 76, 705-712.
102. Ackroyd, R., N. J. Brown, M. F. Davis, T. J. Stephenson, S. L. Marcus, C. J. Stoddard, A. G. Johnson and M. W. R. Reed (2000) Photodynamic therapy for dysplastic Barrett's oesophagus: a prospective double-blind randomised placebo-controlled trial. Gut 47, 612-615.
103. Bedwell, J., A. J. MacRobert, D. Phillips and S. G. Bown (1992) Fluorescence distribution and photodynamic effect of ALA-induced PpIX in the DMH rat colonic tumour model. Br. J. Cancer 65, 818-824.
104. Young, S. W., K. W. Woodburn, M. Wright, T. D. Mody, Q. Fan, J. L. Sessler, W. C. Dow and R. A. Miller (1996) Lutetium texaphyrin (PCI-0123): a near-infrared, water-soluble photosensitizer. Photochem. Photobiol. 63, 892-897.
105. Rockson, S. G., D. P. Lorenz, W. Cheong and K. W. Woodburn (2000) An emerging clinical cardiovascular role for photodynamic therapy. Circulation 102, 2322-2324.
106. Sessler, J. L. and R. A. Miller (2000) Texaphyrins: new drugs with diverse clinical applications in radiation and photodynamic therapy. Biochem. Pharmacol. 59, 733-739.
107. Mang, T. S., R. Allison, G. Hewson, W. Snider and R. Moskowitz (1998) A phase II/III clinical study of tin ethyl etiopurpurin (Purlytin)-induced photodynamic therapy for the treatment of recurrent cutaneous metastatic breast cancer. Cancer J. Sci. Am. 4, 378-384.
108. Kaplan, M. J., R. G. Somers, R. H. Greenburg and J. Ackler (1998) Photodynamic therapy in the management of metastatic cutaneous adenocarcinoma: case reports from phase 1/2 studies using tin ethyl etiopurpurin (SnET2). J. Surg. Oncol. 67, 121-125.
109. Razum, N., A. Snyder and D. Doiron (1996) SnET2: clinical update. Proc. SPIE 2675, 43-46.
110. Pangka, V. S., A. R. Morgan and D. Dolphin (1986) Diels-Alder reactions of protoporphyrin XI dimethyl ester with electron deficient alkynes. J. Org. Chem. 51, 1094-1100.
111. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study group(1999) Photodynamic therapy of subfoveal choroidal neovascularisation in age-related macular degeneration with verteporfin: one-year results of 2 randomised clinical trials - TAP report. Arch. Ophthalmol. 117, 1329-1345.
112. Taber, S. W., V. H. Fingar, C. T. Coots and T. J. Wieman (1998) Photodynamic therapy using mono-L-aspartyl chlorin e6 (Npe6) for the treatment of cutaneous disease: a Phase I clinical study. Clin. Cancer Res. 4, 2741-2746.
113. Kessel, D. J. (1997) Pharmacokinetics of N-aspartyl chlorin e6 in cancer patients. Photochem. Photobiol. 39, 81-83.
114. Kato, H. (2001) Clinical applications of PDT in thoracic medicine. IPA 8th World Congress of Photodynamic Medicine, Vancouver, B.C., Canada.
115. Lightdale, C. J., S. K. Heier, N. E. Marcon, J. S. McCaughan Jr., H. Gerdes, B. F. Overholt, M. V. Sivak Jr., G. V. Stiegmann and H. R. Nava (1995) Photodynamic therapy with porfimer sodium versus thermal ablation therapy with Nd:YAG laser for palliation of esophageal cancer: a multicenter randomized trial. Gastrointest. Endosc. 42, 507-512.
116. Overholt, B. F., M. Panjehpour and J. M. Haydek (1999) Photodynamic therapy for Barrett's esophagus: follow-up in 100 patients. Gastrointest. Endosc. 49, 1-7.
117. Barr, H., N. A. Shepherd, A. Dix, D. J. Roberts, W. C. Tan and N. Krasner (1996) Eradication of high-grade dysplasia in columnar-lined (Barrett's) oesophagus by photodynamic therapy with endogenously generated protoporphyrin IX. Lancet 348, 584-585.
118. Gossner, L., M. Stolte, R. Sroka, K. Rick, A. May, E. G. Hahn and C. Ell (1998) Photodynamic ablation of high-grade dysplasia and early cancer in Barrett's esophagus by means of 5-aminolevulinic acid. Gastroenterology 114, 448-455.
119. Kennedy, J. C., R. H. Pottier and D. C. Pross (1990) Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. J. Photochem. Photobiol. B: Biol. 6, 143-148.
120. Kennedy, J. C. and R. H. Pottier (1992) Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. J. Photochem. Photobiol. B: Biol. 14, 275-292.
121. Omrod, D. and B. Jarvis (2000) Topical aminolevulinic acid HCl photodynamic therapy. Am. J. Clin. Dermatol. 1, 133-139.
122. Fink-Puches, R., A. Hofer, J. Smolle, H. Kerl and P. Wolf (1997) Primary clinical response and long-term follow-up of solar keratoses treated with topically applied 5-aminolevulinic acid and irradiation by different wave bands of light. J. Photochem. Photobiol. B: Biol. 41, 145-151.
123. Cairnduff, F., M. R. Stringer, E. J. Hudson, D. V. Ash and S. B. Brown (1994) Superficial photodynamic therapy with topical 5-aminolaevulinic acid for superficial primary and secondary skin cancer. Br. J. Cancer 69, 605-608.
124. Stables, G. I., M. R. Stringer, D. J. Robinson and D. V. Ash (1997) Large patches of Bowen's disease treated by topical aminolaevulinic acid photodynamic therapy. Br. J. Dermatol. 136, 957-960.
125. Morton, C. A., C. Whitehurst, J. H. McColl, J. V. Moore and R. M. MacKie (2001) Photodynamic therapy for large or multiple patches of Bowen disease and basal cell carcinoma. Arch. Dermatol. 137, 319-324.
126. Soler, A. M., T. Warloe, J. Tausjo and A. Berner (1999) Photodynamic therapy by topical aminolevulinic acid, dimethylsulphoxide and curettage in nodular basal cell carcinoma: a one-year follow-up study. Acta Dermato-Venereol. 79, 204-206.
127. Kloek, J., W. Akkermans and G. M. Beijersbergen van Henegouwen (1998) Derivatives of 5-aminolevulinic acid for photodynamic therapy: enzymatic conversion into protoporphyrin. Photochem. Photobiol. 67, 150-154.
128. Moan, J., L. W. Ma and V. Iani (2001) On the pharmacokinetics of topically applied 5-aminolevulinic acid and two of its esters. Int. J. Cancer 92, 139-143.
129. Stender, I. M., J. Lock-Andersen and H. C. Wulf (1999) Recalcitrant hand and foot warts successfully treated with photodynamic therapy with topical 5-aminolaevulinic acid: a pilot study. Clin. Exp. Dermatol. 24, 154-159.
130. Stender, I. M., R. Na, H. Fogh, C. Gluud and H. C. Wulf (2000) Photodynamic therapy with 5-aminolaevulinic acid or placebo for recalcitrant foot and hand warts: randomised double-blind trial. Lancet 355, 963-966.
131. Robinson, D. J., P. Collins, M. R. Stringer, D. I. Vernon, G. I. Stables, S. B. Brown and R. A. Sheehan-Dare (1999) Improved response of plaque psoriasis after multiple treatments with topical 5-aminolaevulinic acid photodynamic therapy. Acta Dermato-Venereol. 79, 451-455.
132. Hongcharu, W., C. R. Taylor, Y. Chang, D. Aghassi, K. Suthamjariya and R. R. Anderson (2000) Topical ALA-photodynamic therapy for the treatment of acne vulgaris. J. Investig. Dermatol. 115, 183-192.
133. Walther, M. M., T. F. Delaney, P. D. Smith, W. S. Friauf, G. F. Thomas, T. H. Shawker, M. P. Vargas, P. L. Choyke, W. M. Linehan, E. H. Abraham, P. G. Okunieff and E. Glatstein (1997) Phase I trial of photodynamic therapy in the treatment of recurrent superficial transitional cell carcinoma of the bladder. Urology 50, 199-206.
134. Nseyo, U. O., B. Shumaker, E. A. Klein and K. Sutherland (1998) Photodynamic therapy using porfimer sodium as an alternative to cystectomy in patients with refractory transitional cell carcinoma in situ of the bladder. J. Urol. 160, 39-44.
135. Kriegmair, M., R. Baumgartner, W. Lumper, R. Waidelich and A. Hofstetter (1996) Early clinical experience with 5-aminolevulinic acid for the photodynamic therapy of superficial bladder cancer. Br. J. Urol. 77, 667-671.
136. Waidelich, R., H. Stepp, R. Baumgartner, E. Weninger, A. Hofstetter and M. Kriegmair (2001) Clinical experience with 5-aminolevulinic acid and photodynamic therapy for refractory superficial bladder cancer. J. Urol. 165, 1904-1907.
137. Diaz-Jimenez, J. P., J. E. Martinez-Ballarin, A. Llunell, E. Farrero, A. Rodriguez and M. J. Castro (1999) Efficacy and safety of photodynamic therapy versus Nd-YAG laser resection in NSCLC with airway obstruction. Eur. Respir. J. 14, 800-805.
138. Sutedja, T. G. and P. E. Postmus (1996) Photodynamic therapy in lung cancer. A review. J. Photochem. Photobiol. B: Biol. 36, 199-204.
139. Furuse, K., M. Fukuoka, H. Kato, T. Horai, K. Kubota, N. Kodama, Y. Kusunoki, N. Takifuji, T. Okunaka and C. Konaka (1993) A prospective phase II study on photodynamic therapy with photofrin II for centrally located early-stage lung cancer. The Japan Lung Cancer Photodynamic Therapy Study Group. J. Clin. Oncol. 11, 1844-1845.
140. Biel, M. A. (1998) Photodynamic therapy and the treatment of head and neck neoplasia. Laryngoscope 108, 1259-1268.
141. Feyh, J. (1996) Photodynamic therapy for cancers of the head and neck. J. Photochem. Photobiol. B: Biol. 36, 175-177.
142. Muller, P. J. and B. C. Wilson (1995) Photodynamic therapy for recurrent supratentorial gliomas. Semin. Surg. Oncol. 11, 346-354.
143. Muller, P. J. and B. C. Wilson (1996) Photodynamic therapy for malignant newly diagnosed supratentorial gliomas. J. Clin. Laser Med. Surg. 14, 263-270.
144. Bauer, T. W., S. M. Hahn, F. R. Spitz, A. Kachur, E. Glatstein and D. L. Fraker (2001) Preliminary report of photodynamic therapy for intraperitonelal sarcomatosis. Ann. Surg. Oncol. 8, 254-259.
145. Moskal, T. L., T. J. Dougherty, J. D. Urschel, J. G. Antkowiak, A. M. Regal, D. L. Driscoll and H. Takita (1998) Operation and photodynamic therapy for pleural mesothelioma: 6-year follow-up. Ann. Thorac. Surg. 66, 1128-1133.
146. Datta, S. N., C. S. Loh, A. J. MacRobert, S. D. Whatley and P. N. Matthews (1998) Quantitative studies of the kinetics of 5-aminolaevulinic acid-induced fluorescence in bladder transitional cell carcinoma. Br. J. Cancer 78, 1113-1118.
147. Kriegmair, M., R. Baumgartner, R. Knuechel, P. Steinbach, A. Ehsan, W. Lumper, F. Hofstadter and A. Hofstetter (1994) Fluorescence photodetection of neoplastic urothelial lesions following intavesical instillation of 5-aminolevulinic acid. Urology 44, 836-841.
148. Kriegmair, M., D. Zaak, H. Stepp, R. Baumgartner, R. Knuechel and A. Hofstetter (1999) Transurethral resection and surveillance of bladder cancer supported by 5-aminolevulinic acid-induced fluorescence endoscopy. Eur. Urol. 36, 386-392.
149. Jichlinski, P., G. Wagnieres, M. Forrer, J. Mizeret, L. Guillou, M. Oswald, F. Schmidlin, P. Graber, H. Van den Bergh and H. J. Leisinger (1997) Clinical assessment of fluorescence cytoscopy during transurethral bladder resection in superficial bladder cancer. Urol. Res. 25, S3-6.
150. Koenig, F., F. J. McGovern, R. Larne, H. Enquist, K. T. Schomacker and T. F. Deutsch (1999) Diagnosis of bladder carcinoma using protoporphyrin IX fluorescence induced by 5-aminolaevulinic acid. Br. J. Urol. 83, 129-135.
151. Filbeck, T., M. B. Wimmershoff, U. Pichlmeier, S. Karrer, W. F. Wieland, R. M. Szeimies and W. Rossler (2000) No generalized skin phototoxicity after intravesical application of 5-aminolevulinic acid for fluorescence diagnosis of superficial bladder cancer. Urol. Int. 64, 126-128.
152. Baumgartner, R., R. M. Huber, H. Schulz, H. Stepp, K. Rick, F. Gamarra, A. Leberig and C. Roth (1996) Inhalation of 5-aminolevulinic acid: a new technique for fluorescence detection of early stage lung cancer. J. Photochem. Photobiol. B: Biol. 36, 169-174.
153. Messmann, H. (2000) 5-aminolevulinic acid-induced protoporhyrin IX for the detection of gastrointestinal dysplasia. GI Endosc. Clin. N. Am. 10, 497-512.
154. Ladner, D. P., R. A Steiner, J. Allemann, U. Haller and H. Walt (2001) Photodynamic diagnosis of breast tumours after oral application of aminolevulinic acid. Br. J. Cancer 84, 33-37.
155. Whitehurst, C., K. Byrne and J. V. Moore (1993) Development of an alternative light source to lasers for photodynamic therapy: 1. Comparative in vitro dose response characteristics. Lasers Med. Sci. 8, 259-267.